- How to Spot, and Talk About, Hearing Loss in a Loved One
- Estrogen May Trigger Binge Drinking, Prelim Study Suggests
- The Number of Homeless People in the U.S. Has Increased
- Weight-Loss Drugs, Wily Viruses, Abortion Pill Under Attack: The Top Health Stories of 2024
- Use Your Freezer to Fight Food Waste, Protect the Planet
- Heat Waves Threaten Brain Health, Study Suggests
- Norovirus Cases Are Up in Pockets of the U.S.
- CDC Reports Potentially Troublesome Mutations in Bird Flu Found in Louisiana Patient
- Single Peoples’ Personalities Differ from Partnered Peoples’
- Singapore Is Ready for a Rapidly Aging Society, Study Says. What About the U.S.?
Akynzeo Approved for Side Effects of Chemotherapy
The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday in a news release.
Akynzeo contains a new anti-nausea drug, netupitant, and palonosetron, which was approved to treat nausea and vomiting in 2008.
The combination drug’s effectiveness was evaluated in two clinical studies involving 1,720 people. The trials established that Akynzeo was more effective in preventing nausea and vomiting than palonosetron taken alone, the FDA said.
The most frequent side effects of the combination drug included headache, weakness, fatigue, indigestion and constipation.
Akynzeo is marketed and distributed by Eisai Inc. of Woodcliff Lake, N.J., under license from Switzerland-based Helsinn Healthcare.
More information
The FDA has more.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
Estrogen May Trigger Binge Drinking, Prelim Study SuggestsA woman’s binge drinking might be related to her...
- December 31, 2024
-
Some Abortion Pill Users Surprised By Pain, Study SaysAbortion pills are safe and effective, but some pain...
- December 20, 2024
-
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box WarningThe U.S. Food and Drug Administration (FDA) has issued...
- December 18, 2024
-
Non-heterosexual Women Report Better Sexual Functioning During Midlife
TUESDAY, Dec. 17, 2024 A woman’s sex drive often...
- December 18, 2024
-200x224.jpg)
